Back to Products
Tablet
DICSOVIBE-SP
Diclofenac potassium (50 mg), Paracetamol (325 mg), Serratiopeptidase (10 mg)
Ramitra Biotech presents DICSOVIBE-SP, containing Diclofenac potassium (50 mg), Paracetamol (325 mg), Serratiopeptidase (10 mg), a high-trust Tablet in 10 x 10 Aluminium packing validated for quality assurance and certified under WHO-GMP protocols for healthcare providers across India.
📋 Specifications
| Product Name | DICSOVIBE-SP |
|---|---|
| Composition | Diclofenac potassium (50 mg), Paracetamol (325 mg), Serratiopeptidase (10 mg) |
| Category | Tablet |
| Packaging | 10 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
Potent combination for rapid pain relief and inflammation management.
Effectively targets musculoskeletal pain and associated swelling.
Synergistic action of Diclofenac potassium and Paracetamol for enhanced analgesia.
Serratiopeptidase aids in resolving inflammation and promoting tissue repair.
Ideal for post-operative pain, sprains, and strains.
Convenient 10 x 10 Aluminium packaging for optimal stability.
Quantity
